Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 2208-2220

  Mahdi, Layla K ^a   Wang, Hui ^a   Van Der Hoek, Mark B ^a   Paton, James C ^a   Ogunniyi, Abiodun David ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL 3 PHOSPHATE DEHYDROGENASE; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; NOSE INFECTION; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTOMICS; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCEROLPHOSPHATE DEHYDROGENASE; HUMANS; MENINGITIS, PNEUMOCOCCAL; MICE; MUTATION; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TOXOIDS;

EID: 84861805346     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45850     Document Type: Article

References (67)

1. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16(3):217-225.
2. Sakata H, et al. Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan. J Infect Chemother. 2010;16(6):396-406.
3. Nigrovic LE, Kuppermann N, Malley R. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med. 2008;15(6):522-528.
4. Dery MA, Hasbun R. Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep. 2007; 9(4):301-307. (Pubitemid 47162239)
5. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: A systematic review and meta-analysis. J Infect. 2010;61(2):114-124.
6. Singleton RJ, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007; 297(16):1784-1792. (Pubitemid 46658647)
7. Hicks LA, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196(9):1346-1354. (Pubitemid 351412007)
8. Meli DN, Christen S, Leib SL, Tauber MG. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis. 2002; 15(3):253-257. (Pubitemid 34548187)
9. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002;2(12):721-736. (Pubitemid 35434557)
10. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis. 2004; 190(9):1661-1669. (Pubitemid 39411017)
11. Uchiyama S, et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med. 2009;206(9):1845-1852.
12. Meng JP, et al. Identification of Streptococcus pneumoniae genes specifically induced in mouse lung tissues. Can J Microbiol. 2008;54(1):58-65.
13. Blomberg C, et al. Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. J Infect Dis. 2009;199(7):1032-1042.
14. Polissi A, et al. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun. 1998;66(12):5620-5629. (Pubitemid 28531814)
15. Marra A, et al. Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis. Infect Immun. 2002; 70(3):1422-1433. (Pubitemid 34163420)
16. Xu WC, et al. In vivo characterization of Streptococcus pneumoniae genes involved in the pathogenesis of meningitis by differential fluorescence induction. Saudi Med J. 2010;31(4):382-388.
17. Bartilson M, Marra A, Christine J, Asundi JS, Schneider WP, Hromockyj AE. Differential fluorescence induction reveals Streptococcus pneumoniae loci regulated by competence stimulatory peptide. Mol Microbiol. 2001;39(1):126-135. (Pubitemid 32057682)
18. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun. 2004;72(10):5582-5596. (Pubitemid 39303666)
19. Grifantini R, et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol. 2002; 20(9):914-921. (Pubitemid 35001129)
20. Rappuoli R. Reverse vaccinology. Curr Opin Microbiol. 2000;3(5):445-450.
21. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine. 2001;19(17-19):2688-2691. (Pubitemid 32234290)
22. Meinke A, Henics T, Hanner M, Minh DB, Nagy E. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine. 2005;23(17-18):2035-2041. (Pubitemid 40341423)
23. Giefing C, et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med. 2008;205(1):117-131. (Pubitemid 351185720)
24. Molzen TE, et al. Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun. 2011;79(1):288-297.
25. Conway T, Schoolnik GK. Microarray expression profiling: capturing a genome-wide portrait of the transcriptome. Mol Microbiol. 2003;47(4):879-889. (Pubitemid 36232788)
26. LeMessurier KS, Ogunniyi AD, Paton JC. Differential expression of key pneumococcal virulence genes in vivo. Microbiology. 2006;152(pt 2):305-311. (Pubitemid 43210661)
27. Mahdi LK, Ogunniyi AD, LeMessurier KS, Paton JC. Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease. Infect Immun. 2008;76(2):646-657. (Pubitemid 351251735)
28. Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun. 2000;68(1):133-140. (Pubitemid 30016688)
29. Ogunniyi AD, et al. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun. 2007;75(4):1843-1851. (Pubitemid 46559453)
30. Ogunniyi AD, et al. c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. Vaccine. 2008;26(36):4676-4685.
31. Pilo P, et al. A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony. J Bacteriol. 2005;187(19):6824-6831. (Pubitemid 41356256)
32. Bischof DF, Vilei EM, Frey J. Functional and antigenic properties of GlpO from Mycoplasma mycoides subsp. mycoides SC: characterization of a flavin adenine dinucleotide-binding site deletion mutant. Vet Res. 2009;40(4):35.
33. Swartz MN. Bacterial meningitis--a view of the past 90 years. N Engl J Med. 2004;351(18):1826-1828. (Pubitemid 39426317)
34. Claiborne A. Studies on the structure and mechanism of Streptococcus faecium L-alpha-glycerophosphate oxidase. J Biol Chem. 1986;261(31):14398-14407. (Pubitemid 17220220)
35. Pericone CD, Overweg K, Hermans PW, Weiser JN. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 2000;68(7):3990-3997. (Pubitemid 30434551)
36. Pericone CD, Park S, Imlay JA, Weiser JN. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J Bacteriol. 2003;185(23):6815-6825. (Pubitemid 37444484)
37. Bermpohl D, et al. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest. 2005;115(6):1607-1615. (Pubitemid 40814669)
38. Braun JS, et al. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002;109(1):19-27. (Pubitemid 34052538)
39. Hoffmann O, et al. Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide. Infect Immun. 2006;74(9):5058-5066. (Pubitemid 44300423)
40. Hoffmann OM, Becker D, Weber JR. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. J Cereb Blood Flow Metab. 2007; 27(11):1792-1797. (Pubitemid 47624544)
41. Yu J, et al. Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infection. Microbiology. 2001;147(pt 2):431-438. (Pubitemid 32156819)
42. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, Nordstrom CH. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery. 2000;47(3):701-709.
43. Kiyoshima A, Kudo K, Nishida N, Ikeda N. HPLC simultaneous determination of glycerol and mannitol in human tissues for forensic analysis. Forensic Sci Int. 2002;125(2-3):127-133. (Pubitemid 34224134)
44. Spellerberg B, et al. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol. 1996;19(4):803-813. (Pubitemid 26068593)
45. Regev-Yochay G, Trzcinski K, Thompson CM, Lipsitch M, Malley R. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J Bacteriol. 2007;189(18):6532-6539. (Pubitemid 47397358)
46. Paton JC, Andrew PW, Boulnois GJ, Mitchell TJ. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol. 1993;47:89-115. (Pubitemid 23302929)
47. Hirst RA, Sikand KS, Rutman A, Mitchell TJ, Andrew PW, O'Callaghan C. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun. 2000;68(3):1557-1562. (Pubitemid 30108558)
48. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun. 1994; 62(6):2582-2589. (Pubitemid 24157093)
49. Ogunniyi AD, Giammarinaro P, Paton JC. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology. 2002;148(pt 7):2045-2053. (Pubitemid 34785289)
50. Tettelin H, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293(5529):498-506. (Pubitemid 32679078)
51. Hoskins J, et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol. 2001; 183(19):5709-5717. (Pubitemid 32898618)
52. McCluskey J, Hinds J, Husain S, Witney A, Mitchell TJ. A two-component system that controls the expression of pneumococcal surface antigen A (PsaA) and regulates virulence and resistance to oxidative stress in Streptococcus pneumoniae. Mol Microbiol. 2004;51(6):1661-1675. (Pubitemid 38406540)
53. Ogunniyi AD, et al. Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. J Bacteriol. 2010; 192(17):4489-4497.
54. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey S, Dudoit R, Irizarry W, eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, New York, USA: Springer; 2005:397-420.
55. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods. 2003;31(4):265-273. (Pubitemid 37338763)
56. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3(article 3).
57. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods. 2001;25(4):402-408. (Pubitemid 34164012)
58. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z, Pease LR. Gene splicing by overlap extension. Methods Enzymol. 1993;217:270-279. (Pubitemid 23173375)
59. Talbot UM, Paton AW, Paton JC. Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun. 1996;64(9):3772-3777. (Pubitemid 26298704)
60. Cognet I, et al. Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation. J Immunol Methods. 2003; 272(1-2):199-210. (Pubitemid 36050756)
61. Ogunniyi AD, Folland RL, Briles DE, Hollings-head SK, Paton JC. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun. 2000; 68(5):3028-3033. (Pubitemid 30253892)
62. Lacks S, Hotchkiss RD. A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta. 1960;39(3):508-518.
63. Brown JS, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A. 2002;99(26):16969-16974. (Pubitemid 36034082)
64. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect Immun. 2011;79(10):4122-4130.
65. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun. 2007;75(1):350-357. (Pubitemid 46047911)
66. Wang H, Paton JC, Paton AW. Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J Infect Dis. 2007;196(7):1093-1101. (Pubitemid 47580306)
67. Schaper M, Leib SL, Meli DN, Brandes RP, Tauber MG, Christen S. Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis. Infect Immun. 2003; 71(7):4087-4092. (Pubitemid 36753737)